These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 27027427)

  • 41. Comparative pharmacodynamics and plasma concentrations of d-threo-methylphenidate hydrochloride after single doses of d-threo-methylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in a double-blind, placebo-controlled, crossover laboratory school study in children with attention-deficit/hyperactivity disorder.
    Quinn D; Wigal S; Swanson J; Hirsch S; Ottolini Y; Dariani M; Roffman M; Zeldis J; Cooper T
    J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1422-9. PubMed ID: 15502602
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Altered patterns of functional connectivity of posterior cingulate cortex on resting-state magnetic resonance imaging in children with attention-deficit or hyperactivity disorder].
    Yang S; Dong X; Wang SH; Wu T; Ren YL; Wang DD; Tu WJ; Yi Y; Zheng AB
    Zhonghua Yi Xue Za Zhi; 2013 Jun; 93(24):1881-5. PubMed ID: 24124739
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of methylphenidate on functional controllability: a preliminary study in medication-naïve children with ADHD.
    Henry TR; Fogleman ND; Nugiel T; Cohen JR
    Transl Psychiatry; 2022 Dec; 12(1):518. PubMed ID: 36528602
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Functional connectivity in cortico-subcortical brain networks underlying reward processing in attention-deficit/hyperactivity disorder.
    Oldehinkel M; Beckmann CF; Franke B; Hartman CA; Hoekstra PJ; Oosterlaan J; Heslenfeld D; Buitelaar JK; Mennes M
    Neuroimage Clin; 2016; 12():796-805. PubMed ID: 27818941
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Task-related default mode network modulation and inhibitory control in ADHD: effects of motivation and methylphenidate.
    Liddle EB; Hollis C; Batty MJ; Groom MJ; Totman JJ; Liotti M; Scerif G; Liddle PF
    J Child Psychol Psychiatry; 2011 Jul; 52(7):761-71. PubMed ID: 21073458
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An evaluation of the pharmacokinetics of methylphenidate for the treatment of attention-deficit/ hyperactivity disorder.
    Frölich J; Banaschewski T; Döpfner M; Görtz-Dorten A
    Expert Opin Drug Metab Toxicol; 2014 Aug; 10(8):1169-83. PubMed ID: 24856438
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of methylphenidate on very low frequency electroencephalography oscillations in adult ADHD.
    Cooper RE; Skirrow C; Tye C; McLoughlin G; Rijsdijk F; Banaschweski T; Brandeis D; Kuntsi J; Asherson P
    Brain Cogn; 2014 Apr; 86():82-9. PubMed ID: 24594658
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Empathy and Facial Expression Recognition in Children With and Without Attention-Deficit/Hyperactivity Disorder: Effects of Stimulant Medication on Empathic Skills in Children with Attention-Deficit/Hyperactivity Disorder.
    Gumustas F; Yilmaz I; Yulaf Y; Gokce S; Sabuncuoglu O
    J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):433-439. PubMed ID: 28332851
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effects of stimulant medication on working memory functional connectivity in attention-deficit/hyperactivity disorder.
    Wong CG; Stevens MC
    Biol Psychiatry; 2012 Mar; 71(5):458-66. PubMed ID: 22209640
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Osmotic Release Oral System Methylphenidate Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Chinese Youth: 8-Week Comparative Efficacy and 1-Year Follow-Up.
    Su Y; Yang L; Stein MA; Cao Q; Wang Y
    J Child Adolesc Psychopharmacol; 2016 May; 26(4):362-71. PubMed ID: 26779845
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Methylphenidate increased regional cerebral blood flow in subjects with attention deficit/hyperactivity disorder.
    Kim BN; Lee JS; Cho SC; Lee DS
    Yonsei Med J; 2001 Feb; 42(1):19-29. PubMed ID: 11293498
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Methylphenidate Modulates Functional Network Connectivity to Enhance Attention.
    Rosenberg MD; Zhang S; Hsu WT; Scheinost D; Finn ES; Shen X; Constable RT; Li CS; Chun MM
    J Neurosci; 2016 Sep; 36(37):9547-57. PubMed ID: 27629707
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    Quansah E; Ruiz-Rodado V; Grootveld M; Probert F; Zetterström TSC
    Neurochem Int; 2017 Sep; 108():109-120. PubMed ID: 28268188
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Autonomic hypoactivity in boys with attention-deficit/hyperactivity disorder and the influence of methylphenidate.
    Conzelmann A; Gerdes AB; Mucha RF; Weyers P; Lesch KP; Bähne CG; Fallgatter AJ; Renner TJ; Warnke A; Romanos M; Pauli P
    World J Biol Psychiatry; 2014 Jan; 15(1):56-65. PubMed ID: 24410179
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effects of methylphenidate on cognitive function in children with attention-deficit/hyperactivity disorder.
    Kubas HA; Backenson EM; Wilcox G; Piercy JC; Hale JB
    Postgrad Med; 2012 Sep; 124(5):33-48. PubMed ID: 23095424
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term effects of methylphenidate on neural networks associated with executive attention in children with ADHD: results from a longitudinal functional MRI study.
    Konrad K; Neufang S; Fink GR; Herpertz-Dahlmann B
    J Am Acad Child Adolesc Psychiatry; 2007 Dec; 46(12):1633-41. PubMed ID: 18030085
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of osmotic-controlled release oral delivery system methylphenidate HCl in adults with attention-deficit/hyperactivity disorder in Japan.
    Takahashi N; Koh T; Tominaga Y; Saito Y; Kashimoto Y; Matsumura T
    World J Biol Psychiatry; 2014 Aug; 15(6):488-98. PubMed ID: 24456065
    [TBL] [Abstract][Full Text] [Related]  

  • 58. OROS-methylphenidate efficacy on specific executive functioning deficits in adults with ADHD: a randomized, placebo-controlled cross-over study.
    Bron TI; Bijlenga D; Boonstra AM; Breuk M; Pardoen WF; Beekman AT; Kooij JJ
    Eur Neuropsychopharmacol; 2014 Apr; 24(4):519-28. PubMed ID: 24508533
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of d-Methylphenidate, Guanfacine, and Their Combination on Electroencephalogram Resting State Spectral Power in Attention-Deficit/Hyperactivity Disorder.
    Loo SK; Bilder RM; Cho AL; Sturm A; Cowen J; Walshaw P; Levitt J; Del'Homme M; Piacentini J; McGough JJ; McCracken JT
    J Am Acad Child Adolesc Psychiatry; 2016 Aug; 55(8):674-682.e1. PubMed ID: 27453081
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional MRI in attention-deficit hyperactivity disorder: evidence for hypofrontality.
    Zang YF; Jin Z; Weng XC; Zhang L; Zeng YW; Yang L; Wang YF; Seidman LJ; Faraone SV
    Brain Dev; 2005 Dec; 27(8):544-50. PubMed ID: 15876503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.